SpectrumAi, a Los Angeles, CA-based digital health company that develops innovative solutions in the autism space, raised $9 million in seed funding.
The round was co-led by F-Prime Capital and Frist Cressey Ventures, with participation from Autism Impact Fund.
Led by Ling Shao, Founder and CEO, SpectrumAi has developed technology that aims to improve the quality of Applied Behavior Analysis (ABA) therapy, the only treatment currently covered for autism despite a lack of data transparency and objectivity. The technology captures objective quality and outcomes data to improve care for individuals and at a population level, enabling ABA to move to a value-based contracting model. Metrics collected through SpectrumAi will allow for productive conversations between providers, payors, parents and the neurodiverse community. The data will provide additional insights into the care needs of females and minorities with autism.
Along with Ling Shao, SpectrumAi has assembled a team of proven healthcare leaders including:
- Co-founder Elizabeth Bigham as Chief Operating Officer
- Co-founder Chris Storer as Chief Marketing Officer
- Liz Hevenstone as Chief Commercial Officer
- Carl Byers, Partner at F-Prime Capital, as a board member
- Navid Farzad, Partner at Frist Cressey Ventures, as a board member
- Jennifer Kuhn, Chief Network Officer for Anthem, Inc., as a board member
FinSMEs
02/06/2022